脈絡膜新生血管的全球市場調查報告-產業分析，規模，佔有率，成長，趨勢，2022年～2028年前的預測

Value Market Research深入調查脈絡膜新生血管的全球市場，並預測未來幾年行業將出現顯著增長。本研究報告提供全球脈絡膜新生血管市場相關之完全產業分析，提供市場規模、市場佔有率、增長趨勢、2023年至2028年的預測等。該報告以詳細的市場介紹和突出報告關鍵增長數據的執行摘要為首。接續的章節討論市場價值鏈、波特五力模型和市場吸引力分析。同時還設立關於COVID-19影響分析的獨立章節，以瞭解市場如何應對疫情。

本報告的市場動態部分詳細介紹了當前的市場推動因素/阻礙、課題/風險和未來機遇。本節對企業戰略家和新產品開發部門非常有用。脈絡膜新生血管全球市場調查將市場細分化，並根據收益和/或銷售額的視點提供市場規模。該數據地區細分，同時國家/地區細分。數據是通過深入的初級訪談和世界各地的行業專家收集而來。詳細的調查方法可以在樣本報告中找到。這些市場預測受到最新的社會、政治和經濟變化以及影響該脈絡膜新生血管市場的當前市場動態所影響。

脈絡膜新生血管市場報告的子章節提供市場競爭力調查，提供一些領先的市場參與者/製造商簡介。這些章節涵括可深入瞭解競爭對手的產品線、財務狀況、最新發展以及在行業中擁有最高市場佔有率公司所需的豐富資訊。

目錄

第1章 序文

• 本報告的內容
  • 目的
  • 主要讀者
  • 獨特的銷售主張(USP)及提供服務
• 調查範圍
• 調查手法
  • 市場調查流程
  • 市場調查手法

第2章 摘要整理

• 市場概況
• 全球市場概述

第3章 脈絡膜新生血管:產業分析

• 簡介- 市場動態
• 推動市場要素
• 阻礙市場要素
• 商機
• 產業趨勢
• 波特的五力分析
• 市場魅力分析
  • 各產品類型
  • 各診斷類型
  • 各治療類型
  • 各用途
  • 各地區

第4章 價值鏈分析

• 價值鏈分析
• 原料的分析
  • 原料的清單
  • 原料的製造原清單
  • 主要原料的價格趨勢
• 潛在的買主清單
• 銷售管道
  • 直銷
  • 間接行銷
  • 行銷流通管道開拓趨勢

第5章 COVID-19疫情的影響分析

• COVID-19疫情影響分析
  • 對生產的直接性影響
  • 供應鏈與市場的混亂
  • 對企業及金融市場的財務性影響
• COVID-19生產，進口，出口，各需求的影響分析
• 市場COVID-19疫情前/發生後
• 冠狀病毒(COVID-19)疫情的影響預測
• COVID-19:微觀和宏觀的要素分析

第6章 脈絡膜新生血管的全球市場分析:各產品類型

• 概要:各產品類型
• 實際成果資料與預測資料
• 分析:各產品類型
• 靜脈注射的市場:各地區
• 玻璃體內給藥市場:各地區

第7章 脈絡膜新生血管的全球市場分析:各診斷類型

• 各診斷類型概要
• 實際成果資料與預測資料
• 各診斷類型分析
• 螢光素血管造影術(FA)市場:各地區
• 吲哚菁綠(ICG)血管造影術法的市場:各地區
• 頻譜網域光學相干斷層掃瞄(OCT)市場:各地區
• 其他市場:各地區

第8章 脈絡膜新生血管的全球市場分析:各治療類型

• 各治療類型概要
• 實際成果資料與預測資料
• 各治療類型分析
• 血管新生抑制劑注射的市場:各地區
• 光動力療法市場:各地區
• 雷射光凝固療法的市場:各地區
• 低輻射劑量放射線治療市場:各地區
• 手術的市場:各地區

第9章 脈絡膜新生血管的全球市場分析:各用途

• 概要:各用途
• 實際成果資料與預測資料
• 分析:各用途
• 極度近視的市場:各地區
• 惡性近視眼的市場:各地區
• 老齡化伴隨的新興國家開拓市場:各地區

第10章 脈絡膜新生血管的全球市場分析:各地區

• 各地區展望
• 簡介
• 北美
  • 概要，實際成果資料，預測資料
  • 北美:各市場區隔明細
  • 北美:各國資料
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 概要·實際成果·預測資料
  • 歐洲:各市場區隔
  • 歐洲:各國
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他的歐洲地區
• 亞太地區
  • 概要·實際成果·預測資料
  • 亞太地區:各市場區隔
  • 亞太地區:各國資料
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 其他亞太地區
• 南美
  • 概要，實際成果與預測資料
  • 南美:各市場區隔
  • 南美:各國資料
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他的南美地區
• 中東·非洲地區
  • 概要，實際成果與預測資料
  • 中東·非洲地區:各市場區隔
  • 中東·非洲地區:各國一覽
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他的中東·非洲地區

第11章 脈絡膜新生血管治療企業的競爭情形

• 脈絡膜新生血管的市場競爭
• 聯盟·合作·協定
• 合併·收購
• 新產品銷售
• 其他的開發

第12章 企業簡介

• 企業佔有率分析
• 市場集中度
• Bausch Health Companies Inc.
  • 企業概要
  • 產品介紹
  • 最近的開發情形
• Bayer AG
  • 公司概要
  • 產品介紹
  • 最近的開發情形
• Gilead Sciences, Inc.
  • 公司概要
  • 產品資訊
  • 最近的開發情形
• Hoffmann-La Roche Ltd.
  • 公司概要
  • 產品資訊
  • 最近的開發情形
• MaaT Pharma
  • 公司概要
  • 產品資訊
  • 最近的開發情形
• Novartis AG
  • 公司概要
  • 產品資訊
  • 最近的開發情形
• Pfizer Inc.
  • 公司概要
  • 產品資訊
  • 最近的開發情形
• Quark Pharmaceuticals Inc.
  • 公司概要
  • 產品資訊
  • 最近的開發情形
• SBI ALApharma Co. Limited,
  • 公司概要
  • 產品資訊
  • 最近的開發情形
• Regeneron Pharmaceuticals Inc.
  • 公司概要
  • 產品資訊
  • 最近的開發情形
• Sanwa Kagaku Kenkyusho Co. Ltd.
  • 公司概要
  • 產品資訊
  • 最近的開發情形
• Suzuken Co. Ltd.
  • 公司概要
  • 產品資訊
  • 最新資訊

在公司簡介中，財務細節和最近的發展基於可取得的現有信息，可能不包含非上市公司。

Value Market Research deeply researched the Global Choroidal Neovascularization Market to foresee a significant growth in the industry over the upcoming years. The global choroidal neovascularization market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.

The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global choroidal neovascularization market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this choroidal neovascularization market.

The next sections of the choroidal neovascularization market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.

Countries Covered in the report are as below:

North America - United States, Canada, and Mexico

Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe

Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC

Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America

Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa

Market Segmentation in the report is as below:

By Product Type

Intravenous

Intravitreal

By Type of Diagnosis

Fluorescein Angiography (FA)

Indocyanine Green (ICG) Angiography

Spectral Domain Optical Coherence Tomography (OCT)

Others

By Treatment Type

Angiogenesis Inhibitors Injection

Photodynamic Therapy

Laser Photocoagulation

Low-dose Radiation Therapy

Surgery

By Application

Extreme Myopia

Malignant Myopic Degeneration

Age-Related Developments

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . CHOROIDAL NEOVASCULARIZATION - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 By Product Type
  • 3.7.2 By Type of Diagnosis
  • 3.7.3 By Treatment Type
  • 3.7.4 By Application
  • 3.7.5 By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

• 5.1. Impact Analysis of Covid-19 Outbreak
  • 5.1.1. Direct Impact on Production
  • 5.1.2. Supply Chain and Market Disruption
  • 5.1.3. Financial Impact on Firms and Financial Markets
• 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
• 5.3. Market: Pre V/S Post COVID-19
• 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
• 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET ANALYSIS BY PRODUCT TYPE

• 6.1 Overview by Product Type
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product Type
• 6.4 Intravenous Market by Regions
• 6.5 Intravitreal Market by Regions

7 . GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET ANALYSIS BY TYPE OF DIAGNOSIS

• 7.1 Overview by Type of Diagnosis
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Type of Diagnosis
• 7.4 Fluorescein Angiography (FA) Market by Regions
• 7.5 Indocyanine Green (ICG) Angiography Market by Regions
• 7.6 Spectral Domain Optical Coherence Tomography (OCT) Market by Regions
• 7.7 Others Market by Regions

8 . GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET ANALYSIS BY TREATMENT TYPE

• 8.1 Overview by Treatment Type
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Treatment Type
• 8.4 Angiogenesis Inhibitors Injection Market by Regions
• 8.5 Photodynamic Therapy Market by Regions
• 8.6 Laser Photocoagulation Market by Regions
• 8.7 Low-dose Radiation Therapy Market by Regions
• 8.8 Surgery Market by Regions

9 . GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET ANALYSIS BY APPLICATION

• 9.1 Overview by Application
• 9.2 Historical and Forecast Data
• 9.3 Analysis by Application
• 9.4 Extreme Myopia Market by Regions
• 9.5 Malignant Myopic Degeneration Market by Regions
• 9.6 Age-Related Developments Market by Regions

10 . GLOBAL CHOROIDAL NEOVASCULARIZATION MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America
  • 10.3.1. Overview, Historic and Forecast Data
  • 10.3.2. North America By Segment
  • 10.3.3. North America By Country
  • 10.3.4. United State
  • 10.3.5. Canada
  • 10.3.6. Mexico
• 10.4. Europe
  • 10.4.1. Overview, Historic and Forecast Data
  • 10.4.2. Europe by Segment
  • 10.4.3. Europe by Country
  • 10.4.4. United Kingdom
  • 10.4.5. France
  • 10.4.6. Germany
  • 10.4.7. Italy
  • 10.4.8. Russia
  • 10.4.9. Rest Of Europe
• 10.5. Asia Pacific
  • 10.5.1. Overview, Historic and Forecast Data
  • 10.5.2. Asia Pacific by Segment
  • 10.5.3. Asia Pacific by Country
  • 10.5.4. China
  • 10.5.5. India
  • 10.5.6. Japan
  • 10.5.7. South Korea
  • 10.5.8. Australia
  • 10.5.9. Rest Of Asia Pacific
• 10.6. Latin America
  • 10.6.1. Overview, Historic and Forecast Data
  • 10.6.2. Latin America by Segment
  • 10.6.3. Latin America by Country
  • 10.6.4. Brazil
  • 10.6.5. Argentina
  • 10.6.6. Peru
  • 10.6.7. Chile
  • 10.6.8. Rest of Latin America
• 10.7. Middle East & Africa
  • 10.7.1. Overview, Historic and Forecast Data
  • 10.7.2. Middle East & Africa by Segment
  • 10.7.3. Middle East & Africa by Country
  • 10.7.4. Saudi Arabia
  • 10.7.5. UAE
  • 10.7.6. Israel
  • 10.7.7. South Africa
  • 10.7.8. Rest Of Middle East And Africa

11 . COMPETITIVE LANDSCAPE OF THE CHOROIDAL NEOVASCULARIZATION COMPANIES

• 11.1. Choroidal Neovascularization Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF CHOROIDAL NEOVASCULARIZATION INDUSTRY

• 12.1. Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. Bausch Health Companies Inc.
  • 12.3.1. Company Overview
  • 12.3.2. Financials
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. Bayer AG
  • 12.4.1. Company Overview
  • 12.4.2. Financials
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. Gilead Sciences, Inc.
  • 12.5.1. Company Overview
  • 12.5.2. Financials
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. Hoffmann-La Roche Ltd.
  • 12.6.1. Company Overview
  • 12.6.2. Financials
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. MaaT Pharma
  • 12.7.1. Company Overview
  • 12.7.2. Financials
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. Novartis AG
  • 12.8.1. Company Overview
  • 12.8.2. Financials
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. Pfizer Inc.
  • 12.9.1. Company Overview
  • 12.9.2. Financials
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Quark Pharmaceuticals Inc.
  • 12.10.1. Company Overview
  • 12.10.2. Financials
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. SBI ALApharma Co. Limited,
  • 12.11.1. Company Overview
  • 12.11.2. Financials
  • 12.11.3. Products
  • 12.11.4. Recent Developments
• 12.12. Regeneron Pharmaceuticals Inc.
  • 12.12.1. Company Overview
  • 12.12.2. Financials
  • 12.12.3. Products
  • 12.12.4. Recent Developments
• 12.13. Sanwa Kagaku Kenkyusho Co. Ltd.
  • 12.13.1. Company Overview
  • 12.13.2. Financials
  • 12.13.3. Products
  • 12.13.4. Recent Developments
• 12.14. Suzuken Co. Ltd.
  • 12.14.1. Company Overview
  • 12.14.2. Financials
  • 12.14.3. Products
  • 12.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• COVID-19 Impact Analysis by Production, Import, Export and Demand
• Pre V/S Post COVID-19
• Estimated Impact Of The Coronavirus (Covid-19) Epidemic
• COVID-19: Micro and Macro Factor Analysis
• Analysis by Product Type (USD MN)
• Intravenous Market by Geography (USD MN)
• Intravitreal Market by Geography (USD MN)
• Analysis Market by Type of Diagnosis (USD MN)
• Fluorescein Angiography (FA) Market by Geography (USD MN)
• Indocyanine Green (ICG) Angiography Market by Geography (USD MN)
• Spectral Domain Optical Coherence Tomography (OCT) Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Analysis by Treatment Type (USD MN)
• Angiogenesis Inhibitors Injection Market by Geography (USD MN)
• Photodynamic Therapy Market by Geography (USD MN)
• Laser Photocoagulation Market by Geography (USD MN)
• Low-dose Radiation Therapy Market by Geography (USD MN)
• Surgery Market by Geography (USD MN)
• Analysis by Application (USD MN)
• Extreme Myopia Market by Geography (USD MN)
• Malignant Myopic Degeneration Market by Geography (USD MN)
• Age-Related Developments Market by Geography (USD MN)
• Global Choroidal Neovascularization Market by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisiton

LIST OF FIGURES

• Research Scope of Choroidal Neovascularization Report
• Market Research Process
• Market Research Methodology
• Global Choroidal Neovascularization Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product Type
• Market Attractiveness Analysis by Type of Diagnosis
• Market Attractiveness Analysis by Treatment Type
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product Type (USD MN)
• Intravenous Market by Geography (USD MN)
• Intravitreal Market by Geography (USD MN)
• Global Market Analysis by Type of Diagnosis (USD MN)
• Fluorescein Angiography (FA) Market by Geography (USD MN)
• Indocyanine Green (ICG) Angiography Market by Geography (USD MN)
• Spectral Domain Optical Coherence Tomography (OCT) Market by Geography (USD MN)
• Others Market by Geography (USD MN)
• Global Market Analysis by Treatment Type (USD MN)
• Angiogenesis Inhibitors Injection Market by Geography (USD MN)
• Photodynamic Therapy Market by Geography (USD MN)
• Laser Photocoagulation Market by Geography (USD MN)
• Low-dose Radiation Therapy Market by Geography (USD MN)
• Surgery Market by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Extreme Myopia Market by Geography (USD MN)
• Malignant Myopic Degeneration Market by Geography (USD MN)
• Age-Related Developments Market by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Company Market Share Analysis
• Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.